|
The 25-year-old actor has
been all-but-singlehandedly propelling ticket sales at North
American movie theaters, leading two films in the top three
spots on domestic box office charts. Over the weekend, his
action-adventure "Uncharted" repeated No. 1 as his comic book
epic "Spider-Man: No Way Home" followed closely behind in third
place.
"Uncharted," Sony's long-in-the-works video
game adaptation, brought in $23.2 million from 4,275 domestic
venues in its second weekend of release, representing a 46%
decline in revenues from its opening. That brings its domestic
total to $83.3 million. A drop around 50% is standard for
big-budget tentpoles, but making its hold a little more
impressive, the film did not enjoy the rapturous reviews that
greeted "Spider-Man: No Way Home." It helps that "Uncharted" is
based on an extremely popular video game series and caters to
younger males, a demographic that has been reliably going to the
movies during COVID-19.
Meanwhile, another Sony blockbuster "Spider-Man: No Way Home"
took the No. 3 spot with $5.7 million from 3,002 North American
theaters, sliding only 23% in its 11th weekend in theaters.
Since debuting on the big screen in December, the Spidey
threequel has managed to stay in the top three on domestic box
office charts -- a rare feat with or without an
industry-altering pandemic. Through Sunday, "No Way Home" has
collected an enormous $779.8 million in total. Given the movie's
stellar week-to-week holds, "Spider-Man" could soon become the
third movie ever to cross $800 million at the domestic box
office.
In second place, Channing Tatum's PG-13 canine adventure "Dog"
had surprisingly solid attendance levels in its sophomore
outing. The road-trip buddy comedy, from MGM, earned $10.1
million from 3,827 screens over the weekend, pushing its North
American tally to $30.8 million. It's a strong result for a
movie that carries a $15 million production budget. The movie,
which was smartly marketed with the tagline "Don't worry, the
dog doesn't die" in an attempt to win over anyone still reeling
from the 2008 tear-jerker "Marley and Me," continues to perform
in America's heartland. Midwestern and small-town cities have
been leading ticket sales over west and east coast cities and
other major domestic markets.
Two new releases, "Studio 666" and "Cyrano," failed to make a
notable dent on box office charts.
"Studio 666," a horror-comedy-musical-fantasy about Foo Fighters
frontman Dave Grohl and his bandmates as they attempt to record
their 10th studio album, landed in eighth place with $1.5
million from 2,306 North American theaters. The R-rated film got
mixed reviews, though several film critics admitted "Studio 666"
is at least fun to watch. Associated Press critic Jake Coyle
liked the film to "a decent SNL sketch stretched to nearly two
hours" and the New York Times critic at large Wesley Morris
aptly described the movie as exuding "real
'Scooby-Doo'-meets-'The Shining' vibes."
David A. Gross, who runs the movie consulting firm Franchise
Entertainment Research, called "Studio 666" an original oddity,
one that was built around Dave Grohl's and the Foo Fighters
band's popularity. "This is a weak opening, he said, noting
"there aren't many horror comedies in general" at the box
office.
"Cyrano," a romantic musical drama directed by Joe Wright and
starring "Game of Thrones" actor Peter Dinklage, nabbed the No.
9 spot. The well-reviewed film, based on the 2018 stage musical
and Edmond Rostand's 1987 play "Cyrano de Bergerac" about an
emotionally crushing love triangle, opened in just 797 locations
and grossed $1.4 million. Nearly 60% of opening weekend audience
members were female, according to exit polls. MGM will continue
to expand the movie's theatrical footprint in the coming weeks,
but given its $30 million production budget, the profit margins
for "Cyrano" could be more brutal than heartbreak.
[© 2022 Thomson Reuters. All rights
reserved.]
This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|
